Ready to buy? Check current prices on Amazon and compare deals before you decide.
As women navigate perimenopause, many seek ways to support their overall well-being, including their immune system. Ashwagandha (Withania somnifera) is an herb that has garnered interest for its potential health benefits. This article will explore the current, albeit limited, evidence regarding ashwagandha’s role in immune support, particularly for women experiencing midlife changes.
It’s important to approach information about supplements with a balanced perspective. While some studies suggest potential avenues for ashwagandha’s influence on the immune system, much of the research is early-stage, and direct evidence in perimenopausal women is still developing. We’ll outline what the existing research indicates, maintaining a focus on accuracy and avoiding overstatement.
Understanding Ashwagandha’s General Immunomodulatory Potential
Ashwagandha has been studied for its potential to influence the immune system, a concept often referred to as ‘immunomodulation.’ This means it may help regulate or adjust immune responses rather than simply boosting them. Research indicates that Withania somnifera may play a role in modulating inflammatory processes [PMID 36909188, PMID 38414306].
Some preclinical studies have explored how ashwagandha might interact with immune cells. For instance, different chemical profiles (chemotypes) of Withania somnifera have been observed to lead to varying modulated immune responses in animal models [1]. This suggests that the specific composition of an ashwagandha preparation could be relevant to its effects.
A comprehensive review highlighted ashwagandha’s potential ‘geroprotective benefits,’ which include aspects related to enhancing healthspan, with immunomodulation being one of the discussed mechanisms [2]. This broader perspective suggests its potential relevance to age-related physiological changes, which may include aspects of immune function.
Ashwagandha and Stress-Related Immune Factors
Perimenopause can be a time of increased stress for many women, and stress is known to impact immune function. Ashwagandha is often recognized for its adaptogenic properties, which are believed to help the body adapt to stress. Preclinical research has explored ashwagandha’s influence on stress-induced responses, including aspects of inflammation [3].
While this research doesn’t directly link ashwagandha’s stress-modulating effects to improved immune function in perimenopausal women, it offers a potential indirect pathway. By helping the body manage stress, ashwagandha might indirectly support immune resilience, though this connection requires further investigation in human populations.
Early Human Research on Immune Function
While much of the research on ashwagandha and immune support is preclinical, some early human studies are emerging. A pilot randomized, double-blind, placebo-controlled clinical study investigated a standardized combination of Terminalia chebula and Withania somnifera extracts for its effects on immune function in adults. This study suggested that the combination might enhance immune function [4].
It’s important to note that this study involved a combination of herbs, not ashwagandha alone, and was a pilot study. Therefore, these findings are preliminary and cannot be solely attributed to ashwagandha or directly extrapolated to perimenopausal women. More targeted research on ashwagandha’s independent effects in this demographic is needed.
Safety Considerations for Ashwagandha Use
While ashwagandha is generally considered well-tolerated by many, it’s important to be aware of potential considerations, especially when thinking about long-term use or use during perimenopause. Reviews have discussed potential adverse effects of ashwagandha, highlighting the importance of cautious use and further research into its safety profile [5].
Specific attention has been given to ashwagandha’s potential influence on various body systems, including the immune system, as well as reproductive and thyroid systems [6]. While these are areas of ongoing scientific inquiry, it underscores the need for individuals to discuss any supplement use with a healthcare provider, particularly if they have existing health conditions or are taking other medications.
References
- Chemotypical variations in Withania somnifera lead to differentially modulated immune response in BALB/c mice. Vaccine, 2012
- Enhancing healthspan with Ashwagandha (Withania somnifera): a comprehensive review of its multifaceted geroprotective benefits. Biogerontology, 2025
- Modulation by Withania somnifera of stress-induced anxiogenesis and airway inflammation in rats. Journal of complementary & integrative medicine, 2024
- A standardized combination of Terminalia chebula and Withania somnifera extracts enhances immune function in adults: a pilot randomized, double-blind, placebo-controlled clinical study. Food & nutrition research, 2024
- Potential Adverse Effects of Ashwagandha: A Critical Review of Preclinical and Clinical Evidence. Phytotherapy research : PTR, 2026
- Evaluating the Safety of Ashwagandha as a Food Additive: A Focus on Reproductive, Thyroid, and Immune System Effects. Phytotherapy research : PTR, 2025
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
